Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;31(6):563-571.
doi: 10.1097/ICU.0000000000000714.

Drug-induced maculopathy

Mahmood J Khan  1 , Thanos Papakostas  1 , Kyle Kovacs  1 , Mrinali P Gupta  1   2
Affiliations
Review

Drug-induced maculopathy

Mahmood J Khan et al. Curr Opin Ophthalmol. 2020 Nov.

Abstract

Purpose of review: The purpose of this article is to provide an overview of drug-induced maculopathies including their clinical presentations, diagnostic findings, and treatment options. With the increasing pace of development and arrival of drugs to the market, this review aims to inform retina specialists of relevant side effects that may be encountered in a clinical practice setting.

Recent findings: The major themes visited in this article focus on relevant findings of drugs that cause pigmentary and crystalline maculopathy, photoreceptor dysfunction, cystoid macular edema, central serous choroidopathy, uveitis, and vascular damage.

Summary: The current review reports updated findings and discusses the pathophysiologic mechanisms, presentations, and treatments of drug-induced maculopathies.

PubMed Disclaimer

References

    1. Barot RK, Viswanath V, Pattiwar MS, Torsekar RG. Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient. Indian J Ophthalmol 2011; 59:328–329.
    1. Ryan S, Schachat A, Wilkinson C. Retina. 5th Edition. London: Elsevier Health Sciences; 2013. Chapter 89: Drug toxicity of the posterior segment; 1442-1554.
    1. Marmor MF, Kellner U, Lai TYY, et al. American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016; 123:1386–1394.
    1. Yam JCS, Kwok AKH. Ocular toxicity of hydroxychloroquine. Hong Kong Med J 2006; 12:294–304.
    1. Martínez-Costa L, Victoria Ibañez M, Murcia-Bello C, et al. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity. Can J Ophthalmol 2013; 48:400–405.